Autor: "Hanauer, Stephen" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study.
Autorzy:: Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Feagan BG; Western University, London, Ontario, Canada.
Hanauer S; Feinberg School of Medicine, Chicago, IL, USA.
Vermeire S; University of Leuven, Leuven, Belgium.
Ghosh S; University of Calgary, Alberta, Canada.
Liu WJ; Bristol Myers Squibb, Princeton, NJ, USA.
Petersen A; Bristol Myers Squibb, Princeton, NJ, USA.
Charles L; Bristol Myers Squibb, Princeton, NJ, USA.
Huang V; Bristol Myers Squibb, Princeton, NJ, USA.
Usiskin K; Bristol Myers Squibb, Princeton, NJ, USA.
Wolf DC; Center for Crohn's Disease & Ulcerative Colitis, Atlanta Gastroenterology Associates, Atlanta, GA, USA.
D'Haens G; Inflammatory Bowel Disease Center, Amsterdam University Medical Center, Amsterdam, the Netherlands.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2021 Jul 05; Vol. 15 (7), pp. 1120-1129.
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
MeSH Terms:: Colitis, Ulcerative/*drug therapy
Indans/*therapeutic use
Oxadiazoles/*therapeutic use
Sphingosine 1 Phosphate Receptor Modulators/*therapeutic use
Adult ; C-Reactive Protein/metabolism ; Colonoscopy ; Double-Blind Method ; Feces/chemistry ; Female ; Humans ; Leukocyte L1 Antigen Complex/metabolism ; Male ; Remission Induction

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes.
Autorzy:: Christensen B; Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA.; Department of Gastroenterology, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Gastroenterology, Alfred Hospital and Monash University, Melbourne, VIC, Australia.
Hanauer SB; Digestive Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Gibson PR; Department of Gastroenterology, Alfred Hospital and Monash University, Melbourne, VIC, Australia.
Turner JR; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Hart J; Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA.; Department of Pathology, University of Chicago Medicine, Chicago, IL, USA.
Rubin DT; Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2020 Oct 05; Vol. 14 (10), pp. 1345-1353.
Typ publikacji:: Journal Article
MeSH Terms:: Colitis, Ulcerative*/epidemiology
Colitis, Ulcerative*/pathology
Colitis, Ulcerative*/physiopathology
Colitis, Ulcerative*/therapy
Symptom Assessment*/methods
Symptom Assessment*/statistics & numerical data
Biopsy/*methods
Colonoscopy/*methods
Remission Induction/*methods
Adult ; Anti-Inflammatory Agents/therapeutic use ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Intestinal Mucosa/pathology ; Male ; Patient Acuity ; Prognosis ; Progression-Free Survival ; Recurrence ; Retrospective Studies ; Severity of Illness Index ; Smoking/epidemiology ; United States/epidemiology ; Wound Healing

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis.
Autorzy:: Schreiber S; Department of General Internal Medicine, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
Hanauer SB; Digestive Health Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Sandborn WJ; IBD Center, Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Barrett K; Shire, Basingstoke, UK.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2020 Sep 16; Vol. 14 (9), pp. 1274-1281.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Colitis, Ulcerative*/complications
Colitis, Ulcerative*/diagnosis
Colitis, Ulcerative*/drug therapy
Colitis, Ulcerative*/physiopathology
Colonoscopy*/methods
Colonoscopy*/statistics & numerical data
Gastrointestinal Hemorrhage*/diagnosis
Gastrointestinal Hemorrhage*/etiology
Gastrointestinal Hemorrhage*/prevention & control
Mesalamine/*administration & dosage
Remission Induction/*methods
Adult ; Anti-Inflammatory Agents, Non-Steroidal/administration & dosage ; Dose-Response Relationship, Drug ; Double-Blind Method ; Drug Monitoring/methods ; Duration of Therapy ; Female ; Humans ; Male ; Outcome Assessment, Health Care/methods ; Outcome Assessment, Health Care/statistics & numerical data ; Patient Acuity ; Randomized Controlled Trials as Topic ; Severity of Illness Index ; Symptom Assessment/methods ; Symptom Assessment/statistics & numerical data

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials.
Autorzy:: Hanauer S; Northwestern University, Digestive Health Centre, Chicago, IL, USA.
Sandborn WJ; University of California San Diego, Division of Gastroenterology, La Jolla, CA, USA.
Colombel JF; Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, NY, USA.
Vermeire S; University Hospital Leuven, Gastroenterology, Leuven, Belgium.
Petersson J; AbbVie Inc., Global Pharmaceutical Research & Development, North Chicago, IL, USA.
Kligys K; AbbVie Inc., Global Pharmaceutical Research & Development, North Chicago, IL, USA.
Zhou Q; AbbVie Inc., Global Pharmaceutical Research & Development, North Chicago, IL, USA.
Lazar A; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany.
Reinisch W; Medical University of Vienna, Department for Gastroenterology and Hepatology, Vienna, Austria.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2019 Sep 19; Vol. 13 (9), pp. 1227-1233.
Typ publikacji:: Journal Article; Randomized Controlled Trial
MeSH Terms:: Adalimumab/*therapeutic use
Anti-Inflammatory Agents/*therapeutic use
Colitis, Ulcerative/*drug therapy
Adult ; Aged ; Biomarkers/blood ; Blood Proteins/analysis ; C-Reactive Protein/analysis ; Colitis, Ulcerative/pathology ; Erythrocyte Count ; Female ; Hematocrit ; Hemoglobins/analysis ; Humans ; Intestinal Mucosa/pathology ; Male ; Middle Aged ; Platelet Count ; Quality of Life ; Serum Albumin/analysis ; Surveys and Questionnaires

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].
Autorzy:: Travis SP; Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK .
Schnell D; Middletown, OH, USA.
Feagan BG; Robarts Research Institute, University of Western Ontario, London, ON, Canada.
Abreu MT; Division of Gastroenterology, University of Miami Leonard M. Miller School of Medicine, Miami, FL, USA.
Altman DG; Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
Hanauer SB; Digestive Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Krzeski P; Medpace, Warsaw, Poland.
Lichtenstein GR; Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Marteau PR; AP-HP, Hôpital Lariboisière Medicosurgical Department of Digestive Diseases and University Denis Diderot, Paris, France.
Mary JY; INSERM U717 Biostatistics and Clinical Epidemiology, Université Paris Diderot, Paris, France.
Reinisch W; Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, ON, Canada.
Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Schnell P; University of Minnesota, Minneapolis, MN, USA.
Yacyshyn BR; Division of Digestive Diseases, University of Cincinnati, Cincinnati, OH, USA.
Colombel JF; Hôpital Claude Huriez, Centre Hospitalier Universitaire de Lille, Lille, France.
Bernhardt CA; Bernhardt Regulatory Consulting, Cincinnati, OH, USA.
Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2015 Aug; Vol. 9 (8), pp. 607-16. Date of Electronic Publication: 2015 May 08.
Typ publikacji:: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Severity of Illness Index*
Sigmoidoscopy*
Colitis, Ulcerative/*diagnosis
Humans ; Observer Variation ; Single-Blind Method ; Video Recording

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Standard colonic lavage alters the natural state of mucosal-associated microbiota in the human colon.
Autorzy:: Harrell L; Section of Gastroenterology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois, United States of America.
Wang Y
Antonopoulos D
Young V
Lichtenstein L
Huang Y
Hanauer S
Chang E; Pokaż więcej
Źródło:: PloS one [PLoS One] 2012; Vol. 7 (2), pp. e32545. Date of Electronic Publication: 2012 Feb 28.
Typ publikacji:: Controlled Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Colon/*microbiology
Intestinal Mucosa/*microbiology
Adult ; Humans ; Metagenome/genetics ; Middle Aged ; Polymorphism, Restriction Fragment Length/genetics ; RNA, Ribosomal, 16S/genetics ; Sigmoidoscopy

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Hanauer, Stephen"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język